Denali Therapeutics Inc. logo

Denali Therapeutics Inc. (DNLI)

Market Open
11 Sep, 16:03
NASDAQ (NGS) NASDAQ (NGS)
$
21. 14
-0.26
-1.1949%
$
3.54B Market Cap
- P/E Ratio
- Div Yield
22,339 Volume
-1.08 Eps
$ 21.4
Previous Close
Add Transaction
Day Range
21.13 21.79
Year Range
12.58 27.3
Want to track DNLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why

Denali (DNLI) Outperforms Industry in 3 Months: Here's Why

Denali (DNLI) gains 11.9% in three months on positive updates on its candidates.

Zacks | 2 years ago
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Denali Therapeutics (DNLI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks | 2 years ago
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?

Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?

Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 years ago
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program

Denali's (DNLI) Candidate Selected for FDA's START Pilot Program

Denali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START Pilot Program, intended to accelerate the development of rare disease therapies.

Zacks | 2 years ago